The RWD & RWE Podcast
*** Join our weekly Real-World Wednesdays (RWW) Clubhouse room every Wed @ 11am Eastern US Time*** All things related to the collection, creation & use of Real-World Data (RWD) in generating Real-World Evidence (RWE) for clinical research, drug development, medical devices, value access and other activities for BioPharma and the Life Sciences! Real-World Data (RWD): data relating to a person’s health status or well-being, or the care received by a person, as collected from real-world settings (as opposed to the controlled clinical trial setting) [aka observational data, healthcare data, etc.] Real-World Evidence (RWE): the appropriate analysis of RWD Reliable RWD + Appropriate Analysis = Meaningful RWE
Episodes
May 12, 2023
May 12, 2023
39 min
10 May 2023: We’re at ISPOR and we discussed interesting things we saw/heard/learned. ISPOR attendees joined the discussion and provided their thoughts/insights
May 7, 2023
May 7, 2023
57 min
03 May 2023: Conversation with David Lindsay, MD, PhD, CEO of Oncora Medical – We discussed the use of public health real-world data and associated RWE use cases.
Apr 26, 2023
Apr 26, 2023
52 min
26 April 2023: Conversation with Andrea Thoumi MPP MSc and Kamaria Kaalund of the Duke-Margolis Center for Health Policy – We discussed the use of real-world data to inform community-engagement, diversity and inclusiveness across race and ethnicity.
Apr 20, 2023
Apr 20, 2023
1 hr 12 min
19 April 2023: Conversation with Eirini Schlosser, Founder & CEO at Dyania Health – We discussed large language models (LLMs) — what are they, how are they used, what context is needed, availability, deployment — and the ROI of NLP turn healthcare inefficiencies into redundancies
Apr 16, 2023
Apr 16, 2023
1 hr 2 min
12 April 2023: Conversation with Alex Vance MS, SVP Clinical Data Strategy & Operations at Holmusk – We discussed RWD’s role in behavioral healthcare and Life Science research.
Apr 7, 2023
Apr 7, 2023
58 min
05 April 2023: Conversation with Mauro Bucalo, CTO at Biomeris, – We discussed the health data systems in Italy and implementation of standards (e.g., i2b2 & OMOP) to support data analysis and clinical research across health systems.
Mar 30, 2023
Mar 30, 2023
59 min
29 March 2023: Conversation with Jacob Milliron PharmD MHA, Senior National Director, RWD & Solutions at Inovalon – We discussed social determinants of health (SDOH) RWD, specifically use cases where SDOH allows (or enhances) insights to assess and then improve health equity and research in underrepresented patient populations.
Mar 23, 2023
Mar 23, 2023
59 min
22 March 2023: Conversation with Charlie Barr MD MPH, Managing Director and Founder of Pivotal Strategic Consulting, and Sudhir Venkatesan PhD MPH, Director, Medical & Payer Evidence Statistics at AstraZeneca – We discussed considerations to appropriately match cohorts for real-world comparative analyses, including robust propensity score matching, negative controls, etc.
Mar 21, 2023
Mar 21, 2023
56 min
15 March 2023: Conversation with Mal Postings, CEO of Vincigravitas and a RWD industry chief architect – We discussed on the potential value of FHIR & interoperability standards in support of RWE. Where are we now? Is it being used? What are the benefits? What are the challenges?Ten key aspects of FHIR:1. Standards2. Company View3. Interoperability4. Longitudinal Record5. Platforms6. 3rd Party Vendors7. IG’s8. Use Cases9. Federated Analytics10. Futures
Mar 10, 2023
Mar 10, 2023
1 hr 2 min
08 March 2023: Conversation with Hugh Glover, Michael van Campen, Jean Duteau & Craig Parker MD MS FHL7, leadership of the @HL7 Vulcan initiative – First of several sessions as we discuss the much requested topic of FHIR & interoperability standards: Background & HL7 Vulcan. What are interoperability standards? Why are they important? What is HL7 Vulcan and how is it leading the advancement of FHIR in practical and meaningful ways?